SCHEMBL8487546

SCHEMBL8487546

O=[C]N(c1ccccc1)C1CCNCC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 11/20 0.41
SLC6A2 P23975 10/20 0.41
SLC18A3 Q16572 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
NOS2 P35228 1/20 0.40
HRH1 P35367 2/20 0.40
CYP2D6 P10635 2/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
SCN1A P35498 1/20 0.40
KMT2A Q03164 1/20 0.40
SCN2A Q99250 1/20 0.40
SCN3A Q9NY46 1/20 0.40
SLC6A3 Q01959 8/20 0.39
KCNH2 Q12809 2/20 0.38
GBA1 P04062 1/20 0.38
HTR2C P28335 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3245653 0.87 HTT (0.36) MEN1LMNAKMT2A
SCHEMBL14855591 0.85 MEN1 (0.41) MEN1LMNAKMT2A
SCHEMBL14855771 0.83 MEN1 (0.44) MEN1LMNAKMT2A
SCHEMBL10480725 0.82 NOS2 (0.46) SLC6A4SLC6A2SLC18A3SIGMAR1NOS2
SCHEMBL2393892 0.81 MEN1 (0.46) MEN1LMNAKMT2A
SCHEMBL14855820 0.81 MEN1 (0.46) MEN1LMNAKMT2A
SCHEMBL3837450 0.75 SLC6A2 (0.62) SLC6A4SLC6A2SLC18A3SIGMAR1NOS2
SCHEMBL3544485 0.75 SLC18A3 (0.48) SLC6A4SLC6A2SLC18A3SIGMAR1NOS2
SCHEMBL2323552 0.73 SLC6A4 (0.38) SLC6A4SLC6A2CYP2D6MEN1KMT2A
Hydrochloric Acid SCHEMBL18263847 0.73 SLC6A2 (0.60) SLC6A4SLC6A2SLC18A3SIGMAR1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5925635-A 2-(OXO-1,3-PERHYDRODIAZEPINES OR 3-OXO-2,3,4,5-TETRAHYDRO-1H-2,4-BENZODIAZEPINES; ANTICOAGULANTS; ENZYME INHIBITORS OF SERINE PROTEASE THROMBIN, KALLIKREIN AND PLASMIN; NERVOUS SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-07-20 US disclosed